Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 121.00B | 112.36B | 301.02B | 318.98B | 277.07B |
Gross Profit | 121.00B | 136.07B | 301.02B | 318.98B | 277.07B |
EBITDA | 23.73B | 19.85B | 13.31B | 16.45B | 20.59B |
Net Income | 8.43B | 5.37B | 4.30B | 10.95B | 10.46B |
Balance Sheet | |||||
Total Assets | 1.73T | 1.51T | 1.41T | 1.38T | 1.17T |
Cash, Cash Equivalents and Short-Term Investments | 44.39B | 42.55B | 308.46B | 293.80B | 266.36B |
Total Debt | 82.12B | 101.43B | 89.30B | 95.17B | 61.27B |
Total Liabilities | 1.61T | 1.38T | 1.31T | 1.27T | 1.05T |
Stockholders Equity | 87.07B | 78.99B | 75.51B | 88.07B | 90.65B |
Cash Flow | |||||
Free Cash Flow | 116.24B | 127.67B | 88.72B | 94.48B | 110.33B |
Operating Cash Flow | 125.95B | 134.60B | 95.02B | 98.63B | 114.20B |
Investing Cash Flow | -95.63B | -130.95B | -80.30B | -99.62B | -110.85B |
Financing Cash Flow | -27.91B | 34.99B | -9.76B | 9.06B | -945.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | 1.03T | 7.32 | 13.63% | 5.34% | 12.05% | 32.41% | |
75 Outperform | 181.75B | 4.15 | ― | 6.44% | 49.90% | 203.77% | |
75 Outperform | 1.03T | 5.07 | ― | 3.35% | 17.69% | 126.41% | |
70 Outperform | 347.19B | 5.68 | ― | 3.88% | 13.82% | 39.75% | |
69 Neutral | $53.08B | 6.50 | 10.74% | 2.37% | 23.64% | 36.32% | |
69 Neutral | 750.97B | 16.41 | 16.88% | 2.51% | 5.65% | 30.47% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
China Taiping Insurance Holdings reported a robust financial performance for the first half of 2025, with a 12.2% increase in profit attributable to owners, reaching HK$6.764 billion. The company saw significant growth across its life insurance, property and casualty, and reinsurance segments, driven by enhanced insurance service results and strategic initiatives. The company’s total equity and assets also saw substantial increases, reflecting strong investment activities and strategic capital management.
The most recent analyst rating on (HK:0966) stock is a Sell with a HK$11.80 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Company Limited has announced a board meeting scheduled for 28 August 2025 to consider and approve the interim results for the first half of 2025. This meeting is significant as it will address the company’s financial performance and potentially impact its strategic direction, influencing stakeholders’ expectations.
The most recent analyst rating on (HK:0966) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Company Limited has announced the merger of its nomination and remuneration committees into a single entity, the Nomination and Remuneration Committee. This strategic move is aimed at streamlining governance and enhancing the efficiency of board operations, potentially strengthening the company’s industry positioning and providing clearer oversight for stakeholders.
The most recent analyst rating on (HK:0966) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co. has announced the merger of its nomination and remuneration committees into a single entity, the Nomination and Remuneration Committee. This strategic move is aimed at streamlining governance processes and enhancing the board’s efficiency. The committee will consist of a majority of independent non-executive directors and is tasked with reviewing the board’s structure and diversity, as well as identifying and recommending qualified candidates for board positions. This change is expected to strengthen the company’s corporate strategy and ensure a diverse and skilled board composition.
The most recent analyst rating on (HK:0966) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.